{"id":"D1F03971-E0A9-4FCF-B302-5BAC810B3060","title":"Enabling exploitation of novel reagents and assays (EnRgy) to target the inhibition of peptidoglycan biosynthesis","abstractText":"Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.","grantUrl":"http://gtr.rcuk.ac.uk/projects?ref=BB/M005011/1","grantId":"BB/M005011/1","fundValue":"150523","fundStart":"2014-03-14","fundEnd":"2016-03-13","funder":"BBSRC","impactText":"  They have informed global pharma, given them new insight and new approaches for antibiotic discovery, including the development of new screening capabilities in the form of reagents and assays Education,Pharmaceuticals and Medical Biotechnology Economic","person":"Christopher Gerrard Dowson","coPersons":[],"organisation":"University of Warwick","findingsText":" Knowledge transfer from the pharmaceutical antibiotic discovery industry to academia and vice versa. More effective approaches to industry Additional support for academic and industrial leave and engagement Education,Pharmaceuticals and Medical Biotechnology","dataset":"gtr"}